LNSR LENSAR Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LNSR

Price (delayed)

$3.26

Market cap

$37.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.31

Enterprise value

$18.84M

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically ...

Highlights
The EPS is up by 33% YoY
LNSR's revenue is up by 19% year-on-year and by 4.6% since the previous quarter
LENSAR's quick ratio has increased by 33% YoY but it has decreased by 8% QoQ
LENSAR's net income has increased by 28% YoY but it has decreased by 11% QoQ
The equity has contracted by 20% YoY and by 8% from the previous quarter
LENSAR's gross margin has decreased by 11% YoY and by 10% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.lensar.com
Peers: OBIO OM

Key stats

What are the main financial stats of LNSR
Market
Shares outstanding
11.4M
Market cap
$37.15M
Enterprise value
$18.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.1
Price to sales (P/S)
0.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
Earnings
Revenue
$42.16M
EBIT
-$14.38M
EBITDA
-$10.33M
Free cash flow
-$9.9M
Per share
EPS
-$1.31
Free cash flow per share
-$0.9
Book value per share
$2.97
Revenue per share
$3.84
TBVPS
$5.34
Balance sheet
Total assets
$69.59M
Total liabilities
$22.41M
Debt
$2.31M
Equity
$33.43M
Working capital
$34.81M
Liquidity
Debt to equity
0.07
Current ratio
3.99
Quick ratio
2.44
Net debt/EBITDA
1.77
Margins
EBITDA margin
-24.5%
Gross margin
50.1%
Net margin
-34.1%
Operating margin
-29%
Efficiency
Return on assets
-21.8%
Return on equity
-40.5%
Return on invested capital
-54.4%
Return on capital employed
-24.8%
Return on sales
-34.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LNSR stock price

How has the LENSAR stock price performed over time
Intraday
2.52%
1 week
0.62%
1 month
-2.1%
1 year
23.02%
YTD
-7.12%
QTD
-4.03%

Financial performance

How have LENSAR's revenue and profit performed over time
Revenue
$42.16M
Gross profit
$21.11M
Operating income
-$12.23M
Net income
-$14.38M
Gross margin
50.1%
Net margin
-34.1%
LENSAR's operating margin has increased by 49% YoY
LENSAR's net margin has increased by 39% YoY but it has decreased by 6% from the previous quarter
The operating income has grown by 39% YoY but it has contracted by 2.9% from the previous quarter
LENSAR's net income has increased by 28% YoY but it has decreased by 11% QoQ

Growth

What is LENSAR's growth rate over time

Valuation

What is LENSAR stock price valuation
P/E
N/A
P/B
1.1
P/S
0.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
The EPS is up by 33% YoY
The equity has contracted by 20% YoY and by 8% from the previous quarter
LNSR's revenue is up by 19% year-on-year and by 4.6% since the previous quarter
LNSR's P/S is 6% below its last 4 quarters average of 0.9

Efficiency

How efficient is LENSAR business performance
The ROIC has soared by 55% YoY but it has decreased by 2.4% QoQ
The ROS is up by 39% YoY but it is down by 6% QoQ
The ROA has grown by 37% YoY but it has contracted by 5% from the previous quarter
LENSAR's ROE has decreased by 18% from the previous quarter but it has increased by 9% YoY

Dividends

What is LNSR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LNSR.

Financial health

How did LENSAR financials performed over time
LENSAR's total liabilities has soared by 62% YoY and by 8% from the previous quarter
The current ratio is up by 35% year-on-year but it is down by 10% since the previous quarter
LENSAR's debt is 93% less than its equity
The equity has contracted by 20% YoY and by 8% from the previous quarter
LENSAR's debt has decreased by 18% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.